Skip to main content
Clinical Trials/NL-OMON46527
NL-OMON46527WithdrawnNot Applicable

The effect of GBT440 on cerebral perfusion and oxygenation (GBT440-MRI side study) - GBT440-MRI side study

Academisch Medisch Centrum0 sites15 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Subjects have to be included in the HOPE study (GBT440-031 - NL60453.018.17)

Exclusion Criteria

  • 1. Subjects who are excluded from the HOPE study (GBT440-031 - NL60453.018.17)
  • 2. No informed consent has been given
  • 3. Contra-indication for MRI or acetazolamide
  • 4. Previous symptomatic stroke

Investigators

Similar Trials